Tuesday, November 13, 2018 DrugName: COM-902 Compugen Ltd. a clinical-stage cancer immunotherapy company and a leader in predictive target discovery,
Read MoreTuesday, November 13, 2018 Suven Life Sciences Ltd (Suven) announces that the grant of one (1) product patent from Australia
Read MoreWednesday, November 14, 2018 Swedish biopharmaceutical firm Swedish Orphan Biovitrum (Sobi) has signed agreements to acquire the rights to AstraZeneca’s
Read MoreTuesday, November 13, 2018 A survey by the World Health Organization (WHO) has revealed huge variations in the use of
Read MoreTuesday, November 06, 2018 DrugName : adalimumab AbbVie announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under
Read More